Browsing Tag
Boston
68 posts
State Street Q3 profit rises 27% as custody assets reach $59.2tn, but shares weaken
State Street reported stronger earnings, record servicing activity and $6.3 trillion in assets under management, but slower sequential revenue growth and valuation concerns have complicated the market response.
Ironwood Pharmaceuticals (Nasdaq: IRWD) names Tammi Gaskins CEO as LINZESS profits rise
Ironwood Pharmaceuticals has appointed Chief Commercial Officer Tammi Gaskins to succeed Tom McCourt as Chief Executive Officer from January 2027. The succession follows a major 2025 workforce reduction and arrives after sharply stronger LINZESS economics restored profitability, leaving Gaskins to balance cash generation with the late-stage development of apraglutide.
Envestnet to acquire Vestmark as wealth technology platform expands trading capabilities
Envestnet has agreed to acquire Vestmark, bringing institutional trading, tax-transition and portfolio-management technology into a platform associated with roughly $8 trillion of assets, although overlapping customers mean the asset figures cannot simply be added together.
![Ratio Therapeutics’ $70 million Series C financing will support the ATLAS trial of [Ac-225]RTX-2358, expand its targeted radiotherapeutics pipeline and strengthen radiopharmaceutical manufacturing capacity. Representative image.](https://business-news-today.com/wp-content/uploads/2026/07/Ratio-Therapeutics-raises-70-million-to-advance-ATLAS-trial-and-radiopharmaceutical-manufacturing-380x280.png)
Can Ratio Therapeutics turn a $70m funding round into a scalable cancer-treatment platform?
Ratio Therapeutics’ Series C financing gives the Boston oncology company additional capital to advance [Ac-225]RTX-2358, bring another radioligand therapy into clinical development and expand the manufacturing network needed to support a broader cancer pipeline.
Europe has a robotics unicorn, now Humanoid must prove the machines can work
Humanoid’s $152 million Series A gives the UK robotics startup a $1.35 billion valuation, but the real test is whether industrial humanoids can move from promise to reliable deployments at manufacturing and logistics sites.
Eastern Bankshares (EBC) posts record operating income of $106.5m, lifts wealth assets to $11.5bn
Eastern Bankshares posts record $106.5M operating income and a 5% buyback authorization, but CRE payoffs and rising deposit costs test the growth thesis.
Rhythm Pharmaceuticals (RYTM) TRANSCEND trial in NEJM shows 19.8% placebo-adjusted BMI reduction
Rhythm Pharma (RYTM) TRANSCEND Phase 3 published in NEJM validates IMCIVREE for acquired hypothalamic obesity. 10,000-patient US market launch trajectory ahead.
US heat wave puts 185 million under alerts as July 4 events are cancelled
A dangerous US heat wave has put 185 million people under alerts, cancelled July 4 events and strained power grids across major cities.
Could elsunersen become the asset that steadies Praxis Precision Medicines’ CNS pipeline?
Find out how Praxis’ FDA Breakthrough Therapy Designation for elsunersen could affect PRAX stock, rare epilepsy strategy and precision neuroscience today!
Why Trump’s proof-of-citizenship voting order just hit a major court wall
Trump’s proof-of-citizenship voting order faces a major court setback as judges, states and Congress clash over election authority.